Professional Documents
Culture Documents
Noormanto
Division of Pediatric Cardiology,
Departement of Pediatric, Faculty of Medicine
GMU / Sardjito General Hospital Yogyakarta
First described by Tomisaku Kawasaki in
1967 in Japan.
Complication : coronary artery aneurysm
in 20 – 40%
Etiology : unknown
Systemic vasculitis
Epidemiology
Tachycardia
Murmur / gallop
Cardiomegaly
Pericardial effusion
LV dysfunction
ECG changes : PR interval >, low QRS voltage
ST depression/elevation
Laboratory test
not pathognomonic
Leukocytosis with a shift to the left
Mild to moderate anemia
CRP, ESR, alpha1 antitrypsin : during acute
phase
Thrombocytosis : subacute phase may
> 1,000,000 sometimes 2,000,000/mm3
Pyuria (due to urethritis)
Liver enzyme increase, hypoalbuminemia
Elevated CPK : myocard infarction
ECG
Low voltage QRS
ST elevation/depression
QTc >
Wide and deep Q wave
Echocardiography
Mandatory
Detect coronary artery aneurysm and cardiac
dysfunction
May reveal coronary artery changes, depressed
LV function, regurgitation tricuspid, mitral, aortic
and pericardial effusion
Normal coronary size : baby 2 mm, toddler <3
mm, adolescent 5 mm
DIAGNOSTIC CRITERIA
Self limiting
IVIG : clinical improvement within 24 hours and reduce
incidence of Coronary Aneurysm (C.A)
Arterial remodeling or revascularization may occur
coronary artery infarct
Mortality 1-5 % decreasing
Persisting coronary artery ischaemic heart disease at
young adult age
Regressed coronary artery intimal thickening &
endothelium dysfunction premature atherosclerosis
Lifelong monitoring needed?
Risk Factors for coronary aneurysm
Male
Age < 1 year
Other signs or symptoms of pericardial,
myocardial or endocardial involvement,
including arrhythmias
Prolonged period of inflammation,
including fever > 10 days
Recurrence of fever after an afebrile
period of at least 24 hours